Instruction for use: Comari tinctura

Pharmacological group

Other non-narcotic analgesics, including non-steroidal and other anti-inflammatory drugs

Nosological classification (ICD-10)

M13.9 Arthritis, unspecified

Arthritis,Purulent arthritis (non-infectious), acute Arthritis,Pain in acute inflammatory diseases of the musculoskeletal system,Pain in chronic inflammatory diseases of the musculoskeletal system,The pain in osteoarthritis, Inflammation in osteoarthritis, Inflammatory arthropathy, Inflammatory and degenerative joint diseases, Inflammatory disease of the musculoskeletal system, Inflammatory joint disease, Inflammatory diseases of the musculoskeletal system, destructive arthritis, The disease of the musculoskeletal system, Diseases of the musculoskeletal system, Diseases of the musculoskeletal system and connective tissue, Infections musculoskeletal system, monoartrit, Non-infectious arthritis, rheumatic arthritis, Osteoarthritis, Acute inflammation of the musculoskeletal tissue, Acute inflammatory diseases of the musculoskeletal system, Acute inflammatory condition of the musculoskeletal system, Acute arthritis, Acute osteoarthritis, Post-traumatic osteoarthritis, Reactive arthritis, Chronic inflammatory diseases of the joints, Chronic arthritis, Chronic inflammatory arthritis, Chronic inflammation of the inner layer of the joint capsule, Chronic inflammation of the joint capsule,Chronic inflammatory disease of the joints, Exudative arthritis

M19.9 Arthrosis, unspecified

Change in brush with osteoarthritis, Osteoarthritis, Osteoarthrosis, Arthrosis of large joints, Pain syndrome in osteoarthritis, Pain syndrome in acute inflammatory diseases of the musculoskeletal system, Pain syndrome in chronic inflammatory diseases of the musculoskeletal system, Deforming arthrosis, Deforming osteoarthritis, Deforming osteoarthritis of joints, Osteoarthritis in the acute stage, Osteoarthritis of large joints, Acute pain syndrome with osteoarthritis, Post-traumatic osteoarthritis, Rheumatic osteoarthritis, Spondylarthrosis, Chronic osteoarthritis

Composition

Tincture of 1000 ml

Active ingredient:

sabelnik marsh rootstock 100 g

excipient: ethanol (ethyl alcohol) 40% - sufficient to produce 1000 ml of the preparation

Description of dosage form

Tincture: clear liquid from yellow-brown to reddish-brown color with a specific smell. Opalescence is allowed, precipitation may occur during storage.

pharmachologic effect

Pharmacological action - anti-inflammatory, analgesic.

Pharmacodynamics

Has a pronounced anti-inflammatory and analgesic effect.

Indications

In the complex therapy of inflammatory and degenerative diseases of the musculoskeletal system, incl. arthritis, arthrosis.

Contraindications

hypersensitivity to the components of the drug;

children's age till 18 years.

With caution (in connection with the content of ethyl alcohol): severe violations of the liver; trauma and brain disease; epilepsy; chronic alcoholism. Persons who have chronic diseases should consult a doctor before using the drug.

pregnancy and lactation

The drug is contraindicated for use during pregnancy and during breastfeeding.

Side effects

Rarely - allergic reactions, nausea, diarrhea are possible.

Interaction

When using the tincture of the sapelnik in combination with NSAIDs, the therapeutic effect is enhanced, which allows reducing the therapeutic dose of NSAIDs.

Dosing and Administration

Inside. 1 tsp liqueur, previously diluted in 1/3 cup water, 2 times a day, before meals. The course of treatment - 2 months. If necessary, the course of treatment can be repeated after consultation with the doctor.

Overdose

Symptoms: when the drug is used in doses that are much higher than recommended, alcohol poisoning is possible.

Treatment: symptomatic.

special instructions

In the treatment of possible short-term exacerbation of pain syndrome, which passes by itself, without drug discontinuation.

A single dose of the drug contains 1.58 g (2 ml) of absolute alcohol; daily dose of 3.16 g (4 ml). Do not exceed the indicated daily dose.

Influence on the ability to drive vehicles and work with machinery. During the period of drug treatment, care should be taken when driving vehicles and engaging in other potentially hazardous activities requiring increased concentration of attention and speed of psychomotor reactions.

Form of issue

Tincture. In bottles made of brown or orange glass for drugs, 50, 100 ml. Each bottle in a pack of cardboard.

Conditions of leave from pharmacies

Without recipe.

storage Conditions

At a temperature of no higher than 25 ° C.

Keep out of the reach of children.

Shelf life

2 years.

Do not use after the expiry date printed on the package.